Diagnostic usefulness of serum interleukin 6 (IL‐6) and C‐reactive protein (CRP) in the differentiation between pancreatic cancer and chronic pancreatitis

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of clinical laboratory analysis (Print)

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/jcla.20395PMID 20626020PMCID PMC6647747
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Significance of Interleukin-6 (Il-6) Gene Polymorphism and Il-6 Serum Level in Pancreatic Adenocarcinoma and Chronic Pancreatitis

  2009cited by this paper
• Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas.

  2008cited by this paper
• Acute-phase response proteins are related to cachexia and accelerated angiogenesis in gastroesophageal cancers

  2008cited by this paper
• Serum interleukin 6 (IL-6) and C-reactive protein (CRP) levels in colorectal adenoma and cancer patients

  2008cited by this paper
• Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patients

  2007cited by this paper
• Predictive factors in pancreatic ductal adenocarcinoma: Role of the inflammatory response

  2007cited by this paper
• Serum interleukin-6 levels in patients with gastric MALT lymphoma compared to gastric and pancreatic cancer.

  2006cited by this paper
• Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival

  2006cited by this paper
• Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications.

  2005cited by this paper
• Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry

  2005cited by this paper
• Surgical palliation in pancreatic cancer.

  2004cited by this paper
• Cytokines in pancreatic carcinoma

  2004cited by this paper
• Cancer Statistics, 2003

  2003cited by this paper
• Prognostic factors in the palliation of pancreatic cancer.

  2003cited by this paper
• Function of C-reactive protein.

  2000cited by this paper
• Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor

  2000cited by this paper
• Prognostic Factors in Patients with Metastatic Pancreatic Adenocarcinoma Receiving Systemic Chemotherapy

  2000cited by this paper
• Surgical palliation of pancreatic cancer.

  2000cited by this paper
• Function of C-reactive protein

  2000cited by this paper
• Tumor size and lymph-node status in pancreatic carcinoma — is there a correlation to the preoperative immune function?

  1999cited by this paper
• Relationship of serum levels of interleukin-6, soluble interleukin-6 receptor and tumour necrosis factor receptors to the acute-phase protein response in advanced pancreatic cancer.

  1999cited by this paper
• Elevated serum interleukin-6 levels in patients with pancreatic cancer.

  1998cited by this paper
• Cancer statistics

  1989cited by this paper

• Integrating Body Composition and Nutritional Indices: A Novel Prognostic Tool for Survival in Pancreatic Cancer

  2025cites this paper
• RNA biosensors for detection of pancreatic cancer.

  2025cites this paper
• The Relationship Between Metabolic and Inflammatory Parameters at the Time of Diagnosis and Disease Stage and Prognosis in Patients with Pancreatic Cancer

  2025cites this paper
• Identification of biomarkers and potential therapeutic targets for pancreatic cancer by proteomic analysis in two prospective cohorts

  2024cites this paper
• Herbal Remedies and Modern Pharmacology: A Comprehensive Approach to Inflammation Management

  2024cites this paper
• Efficiency of electrochemical immuno- vs. apta(geno)sensors for multiple cancer biomarkers detection.

  2024cites this paper
• Evaluation of urinary C-reactive protein as an early detection biomarker for pancreatic ductal adenocarcinoma

  2024cites this paper
• Advancements in Early Detection and Screening Strategies for Pancreatic Cancer: From Genetic Susceptibility to Novel Biomarkers

  2024cites this paper
• Circulating Biomarkers Involved in the Development of and Progression to Chronic Pancreatitis—A Literature Review

  2024cites this paper
• Circulating immune signatures in chronic pancreatitis with and without preceding acute pancreatitis: A pilot study.

  2024cites this paper
• Targeting interleukin-6 as a treatment approach for peritoneal carcinomatosis

  2024cites this paper
• Relationship between mast cell, angiogenesis and pancreatic cancer: Our experience

  2024cites this paper
• Combined analytical approach empowers precise spectroscopic interpretation of subcellular components of pancreatic cancer cells

  2023cites this paper
• Serum cytokine profiles in patients with pancreatic cancer and chronic pancreatitis.

  2023cites this paper
• Vibrational spectroscopy – are we close to finding a solution for early pancreatic cancer diagnosis?

  2023cites this paper
• Earlier Diagnosis of Pancreatic Cancer: Is It Possible?

  2023cites this paper
• A systematic review and meta-analysis to evaluate blood levels of interleukin-6 in lung cancer patients

  2023cites this paper
• Pre-transplant CRP–albumin ratio as a biomarker in patients receiving haploidentical allogeneic hematopoietic transplantation: Developing a novel DRCI-based nomogram

  2023cites this paper
• Current Pathology Model of Pancreatic Cancer

  2022cites this paper
• Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy

  2022cites this paper
• Predictive Value of Malignancy Index in Tumour Staging in Prostate Cancer

  2022cites this paper
• Circulating tumor DNA: a help to guide therapeutic strategy in patients with borderline and locally advanced pancreatic adenocarcinoma?

  2022cites this paper
• Association of inflammatory markers with the disease & mutation status in pancreatic cancer

  2022cites this paper
• Review of clinical and emerging biomarkers for early diagnosis and treatment management of pancreatic cancer: towards personalised medicine

  2021cites this paper
• Prediagnostic Inflammation and Pancreatic Cancer Survival.

  2021cites this paper
• Ion Channels Orchestrate Pancreatic Ductal Adenocarcinoma Progression and Therapy

  2021influential citation
• Biomarkers of Chronic Pancreatitis: A systematic literature review.

  2021cites this paper
• Chemical Investigation of Marine‐Derived Fungus Aspergillus flavipes for Potential Anti‐Inflammatory Agents

  2021cites this paper
• Clinical Significance of Serial Measurements of Interleukin-6 and High-Sensitivity C-Reactive Protein as Early Predictor of Poor Neurological Outcome in Aneurysmal Subarachnoid Haemorrhage

  2021cites this paper
• Unravelling the broader complexity of IL-6 involvement in health and disease.

  2021cites this paper
• Peripheral blood and tissue assessment highlights differential tumor-circulatory gradients of IL2 and MIF with prognostic significance in resectable pancreatic ductal adenocarcinoma

  2021cites this paper
• Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?

  2021cites this paper
• Rapid, highly sensitive and quantitative detection of interleukin 6 based on SERS magnetic immunoassay.

  2021cites this paper
• Anti-tumour effect of tocilizumab for osteosarcoma cell lines

  2020cites this paper
• Role of imaging biomarkers for prognostic prediction in patients with pancreatic ductal adenocarcinoma.

  2020cites this paper
• Prognostic role of the pretreatment C-reactive protein/albumin ratio in gastric cancer

  2020cites this paper
• Periodontal therapy and cardiovascular risk.

  2020cites this paper
• Emerging roles for the IL-6 family of cytokines in pancreatic cancer

  2020cites this paper
• Malnutrition in Chronic Pancreatitis: Causes, Assessment Methods, and Therapeutic Management

  2020cites this paper
• Serum interleukin-6 level is correlated with the disease activity of systemic lupus erythematosus: a meta-analysis

  2020cites this paper
• Prognostic value of the early change in neutrophil-to-lymphocyte ratio in metastatic pancreatic adenocarcinoma.

  2020cites this paper
• Inflammation, Tumoral Markers and Interleukin-17, -10, and -6 Profiles in Pancreatic Adenocarcinoma and Chronic Pancreatitis

  2020cites this paper
• Cytokines in Inflammatory Disease

  2019cites this paper
• Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?

  2019cites this paper
• Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study

  2019cites this paper
• Novel potential biomarkers for pancreatic cancer - A systematic review.

  2019cites this paper
• Plasma inflammatory cytokines and survival of pancreatic cancer patients

  2018cites this paper
• Clinical significance of combined detection of interleukin-6 and tumour markers in lung cancer

  2018cites this paper
• Nutrition and Inflammatory Biomarkers in Chronic Pancreatitis Patients.

  2018cites this paper
• Postoperative Interleukin-6 Predicts Intra-abdominal Septic Complications at an Early Stage After Elective Intestinal Operation for Crohn's Disease Patients.

  2018cites this paper
• LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker.

  2018cites this paper
• C‐reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer

  2018cites this paper
• The Combination of Neutrophil–to–lymphocyte Ratio and Serum Carbohydrate Antigen 19-9 Level as a Prognostic Indicator in Patients with Recurrent Pancreatic Cancer

  2018cites this paper
• Characterization of the duodenal bacterial microbiota in patients with pancreatic head cancer vs. healthy controls.

  2018cites this paper
• Predicative values of C-reactive protein for the therapeutic effects of ulinastatin combined with somatostatin in severe acute pancreatitis and for the severity of gastrointestinal failure.

  2018cites this paper
• Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer

  2018influential citation
• Kras and Tumor Immunity: Friend or Foe?

  2018cites this paper
• The role of human bone marrow mesenchymal stromal cells in pancreatic cancer growth

  2017cites this paper
• Novel Diagnostic and Predictive Biomarkers in Pancreatic Adenocarcinoma

  2017cites this paper
• Physiology and Pathology of Cytokine: Commercial Production and Medical Use

  2017cites this paper
• IL-6 roles - Molecular pathway and clinical implication in pancreatic cancer - A systemic review.

  2017cites this paper
• Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward

  2017cites this paper
• The diagnostic and prognostic value of interleukin-6 in patients with soft tissue sarcomas

  2017cites this paper
• Elevated Systemic IL-6 Levels in Patients with Aneurysmal Subarachnoid Hemorrhage Is an Unspecific Marker for Post-SAH Complications

  2017cites this paper
• The role of miR-23a~24~27a cluster in the pathogenesis of treatment resistant rheumatoid arthritis

  2017cites this paper
• Inflammatory Potential of Diet And Pancreatic Cancer Risk: Interaction And Mediation Analysis In Two Prospective Cohorts

  2017cites this paper
• IL6 Receptor Blockade Enhances Chemotherapy Efficacy in Pancreatic Ductal Adenocarcinoma

  2017cites this paper
• Inflammatory cytokines and angiogenic factors as potential biomarkers in South African pancreatic ductal adenocarcinoma patients: A preliminary report.

  2017cites this paper
• Exploring the role of Interleukin-6 and other host-associated factors in tumor progression and metastasis development

  2017cites this paper
• C-Reactive protein: a major inflammatory biomarker

  2017cites this paper
• Local proliferation of Ly6C+ monocytes in inflamed tissues and during bacterial infections

  2017cites this paper
• Dachaihu decoction ameliorates pancreatic fibrosis by inhibiting macrophage infiltration in chronic pancreatitis

  2017cites this paper
• The role of inflammatory modulators in chronic pancreatitis and the development of pancreatic cancer

  2017cites this paper
• The C-reactive protein/albumin ratio, a validated prognostic score, predicts outcome of surgical renal cell carcinoma patients

  2017cites this paper
• Cytokine Regulation of Metastasis and Tumorigenicity.

  2016cites this paper
• Inflammation and Inflammatory Diseases, Markers, and Mediators: Role of CRP in Some Inflammatory Diseases

  2016cites this paper
• Paraneoplastic thrombocytosis in gastrointestinal cancer

  2016cites this paper
• Cytokine patterns in cancer patients: A review of the correlation between interleukin 6 and prognosis

  2016cites this paper
• Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review

  2016influential citation
• Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy

  2016cites this paper
• HDAC3 mediates smoking-induced pancreatic cancer

  2016cites this paper
• Biology of C Reactive Protein in Health and Disease

  2016cites this paper
• Characterization of Mouse Models of Early Pancreatic Lesions Induced by Alcohol and Chronic Pancreatitis

  2015cites this paper
• Interleukin-6 as a prognostic marker in dogs in an intensive care unit.

  2015cites this paper
• Analysis of global gene expression profiles suggests a role of acute inflammation in type 3C diabetes mellitus caused by pancreatic ductal adenocarcinoma

  2015cites this paper
• Apigenin inhibits pancreatic stellate cell activity in pancreatitis.

  2015cites this paper
• Chronic Pancreatitis as an Inductor of Pancreatic Cancer — Correlations With Inflammatory Pathways

  2015cites this paper
• IL-6 as a keystone cytokine in health and disease

  2015cites this paper
• Interleukin-6 in inflammatory and malignant diseases of the pancreas.

  2014cites this paper
• The immune network in pancreatic cancer development and progression

  2014cites this paper
• Development of serum parameters panels for the early detection of pancreatic cancer

  2014influential citation
• Interleukin-6: a villain in the drama of pancreatic cancer development and progression.

  2014cites this paper
• Prediagnostic Serum Biomarkers as Early Detection Tools for Pancreatic Cancer in a Large Prospective Cohort Study

  2014cites this paper
• Proinflammatory Factors Cells upon Stimulation with Proteome Variations in Pancreatic Stellate Genomics and Proteomics :

  2013cites this paper
• Inflammatory Plasma Markers and Pancreatic Cancer Risk: a Prospective Study of 5 U.S. Cohorts

  2013cites this paper
• Proteome Variations in Pancreatic Stellate Cells upon Stimulation with Proinflammatory Factors*

  2013cites this paper
• Inflammatory Plasma Markers and Pancreatic Cancer Risk: A Prospective Study of Five U.S. Cohorts

  2013cites this paper
• Comparative Evaluation of Serum C‐Reactive Protein (CRP) Levels in the Different Histological Subtypes of Esophageal Cancer (Squamous Cell Carcinoma and Adenocarcinoma of Esophagus)

  2012cites this paper
• 1 Acute Phase Proteins as Cancer Biomarkers

  2012cites this paper
• Novel compound SK-1009 suppresses interleukin-6 expression through modulation of activation of nuclear factor-kappaB pathway.

  2012cites this paper